Action potential duration (APD) in rabbit ventricular myocardium shortens after a rest period (postrest shortening). However, the effects of preceding stimulus frequency on the postrest shortening have not been elucidated. We recorded transmembrane action potentials (TAPs) and monophasic action potentials (MAPs) from the rabbit ventricle. In in vitro experiments, repetitive regular stimuli (S1) at cycle lengths ranging between 500 to 3000 ms were followed by a single extrastimulus (S2) at a coupling interval of 5000 ms. A decrease in S1S1 interval resulted in a progressive shortening of the duration of TAP (TAPD) elicited by S2 (S2-TAPD), which was potentiated by increasing extracellular calcium concentration ([Ca 2+ ] o ) or application of ouabain and was inhibited by lowering [Ca 2+ ] o or verapamil. Application of ryanodine was most effective in lengthening S2-TAPD following a short S1S1 interval. 4-aminopyridine and E4031 caused marked lengthening of S2-TAPD when S1S1 was long. However, the lengthening effect was attenuated and disappeared with a shorter S1S1 interval. In in vivo experiments, regular ventricular pacing (S1) at cycle lengths ranging between 250 to 1000 ms was followed by a single extrastimulus (S2) with a coupling interval (S1S2) of 1500 ms. A decrease in the S1S1 interval also resulted in progressive shortening of the duration of MAP elicited by S2. Our results indicate that the postrest shortening is potentiated by an increase in the preceding stimulus frequency in the rabbit ventricle, in which the function of sarcoplasmic reticulum may play a significant role. (Jpn Heart J 2000; 41: 481-492) 
onstrated that an abrupt lengthening of the preceding diastolic interval results in a shortening of APD (postrest shortening) both in vitro and in vivo.
3) Postrest shortening was inhibited to a certain extent by the application of 4-aminopyridine (4-AP) at a dose of up to 10 mM. However, additional application of ryanodine was required to completely abolish the postrest shortening.
3) These observations indicate involvement of the sarcoplasmic reticulum (SR), in addition to the slower recovery from inactivation in the 4-AP sensitive transient outward current (Ito), 4, 5) in the regulation of the APD after a prolonged pause. We therefore hypothesized that an increase in conditioning stimulus frequency preceding the rest period enhances utilization of activator calcium (Ca 2+ ) released from the SR, resulting in potentiation of the postrest shortening. In the present study, we tested this hypothesis in rabbits by recording transmembrane action potentials in vitro and monophasic action potentials in vivo.
METHODS

In vitro experiments:
Male Japanese white rabbits (n = 23) weighing 1.8 -2.3 kg were anesthetized with intravenous secobarbital (80 mg / kg) and their hearts rapidly removed through a median sternotomy. Papillary muscles measuring 0.5 to 1.0 mm in diameter were dissected from the right ventricle, pinned on a silicon plate in a 2 ml chamber, and then superfused with Tyrode's solution containing (in mM) 125.0 NaCl, 4.5 KCl, 1.8 CaCl 2 , 1.05 MgCl 2 , 0.42 NaH 2 PO 4 , 24.0 NaHCO 3 , and 10.0 glucose. This solution was gassed continuously with 95% O 2 and 5% CO 2 , and the bath pH was maintained between 7.3 and 7.4. The bath temperature was kept at 36 ± 0.5°C. Transmembrane action potentials (TAPs) were recorded with glass microelectrodes filled with 3M KCl which had tip resistances ranging from 8 to 20 MΩ. The electrodes were connected to a high input-impedance amplifier capable of negative capacitative feedback compensation (HEZ-7101, Nihon Kohden, Japan). The amplified signals were displayed on a dual-beam memory oscilloscope (VC-10, Nihon Kohden) and stored in a PCM data recorder (RD-101T, TEAC, Japan) for later analysis. The papillary muscle strips were electrically stimulated at their proximal ends with rectangular pulses (2 ms pulse duration and twice the diastolic threshold in intensity) applied through a pair of thin silver electrodes. The duration of each TAP (TAPD) was measured at the levels of 30% (TAPD 30 ) and 90% repolarization (TAPD 90 ).
The preparations were paced at a cycle length of 1000 ms in Tyrode's solution and then allowed to stabilize for one hour. The following pacing protocol was then performed. One set of regular stimuli for 60 s (S1) with variable cycle length (3000, 2000, 1000, 700 and 500 ms) was followed by a single stimulus (S2) with a fixed coupling interval of 5000 ms. TAPs recorded in response to the last S1 (S1-TAP) and S2 (S2-TAP) stimuli were measured for their durations (S1-TAPD and S2-TAPD). The same pacing protocol was performed during several pharmacological interventions, which influence intracellular Ca 2+ concentration [Ca 2+ ] i and potassium currents. In vivo experiments : Male Japanese white rabbits (n = 5) weighing 2.7-3.3 kg were anesthetized with intravenous secobarbital (20 mg / kg) and anesthesia was maintained with supplemental doses as required. The animals were ventilated with room air via a tracheal cannula connected to an artificial ventilator (SN-480-5, Shinano, Japan). The tidal volume and respiratory rate were adjusted to keep blood gases and pH within the physiological range. Rectal temperature was maintained at 38 to 39°C using a heating pad. A saline-filled polyethylene catheter (0.8 mm in diameter) was inserted into the femoral artery for monitoring blood pressure. After a median sternotomy, the heart was exposed and suspended in the pericardial cradle. Monophasic action potentials (MAPs) were recorded from the left ventricular endocardium with the contact electrode technique, 6) simultaneously with a standard limb ECG (lead II) and femoral arterial blood pressure. The methods of recording and stability of MAPs under these conditions were described in detail in a previous report. 7) All signals were monitored on a heat-pen recorder (CP-642G, Nihon Kohden, Japan) and stored in a PCM data recorder (RD-111T, TEAC, Japan) for later analysis. The MAP duration (MAPD) was measured at the levels of 30% (MAPD 30 ) and 90% repolarization (MAPD 90 ).
In order to slow the sinus rhythm, we stimulated vagus nerve electrically. 3, 8) To accomplish this, the right cervical vagus nerve was carefully isolated and then stimulated with square pulses (2 ms duration at 50 Hz) delivered by an electronic stimulator (SEC-7203, Nihon Kohden).
3) The intensity of vagal stimulation was set at a level to cause sinus arrest for longer than 3000 ms. The selected intensity was fixed throughout the experiments. To achieve ventricular pacing, a bipolar electrode was placed on the right ventricular outflow tract. This pacing was performed, using a programmable cardiac stimulator (SEC-3102, Nihon Kohden) by delivering square pulses of 2 ms duration at an intensity that was twice the diastolic threshold. For the pacing protocol, one set of regular stimuli for 10 s (S1) with variable cycle length (100, 700, 400 and 250 ms) was followed by a single stimulus (S2) with a fixed coupling interval of 1500 ms. The MAPs obtained in response to the last S1 (S1-MAP) and the S2 (S2-MAP) were measured for their durations (S1-MAPD and S2-MAPD, respectively).
All procedures met the guidelines of the Physiological Society of Japan on the care and use of the laboratory animals, and the experimental protocol was approved by the Animal Research Committee of Oita Medical University. Statistical analysis: The data are expressed as mean ± SEM unless otherwise specified. Changes in each parameter as a function of S1S1 interval by various pharmacological interventions were evaluated for statistical significance using repeated measures analysis of variance (ANOVA). Differences within the groups at each S1S1 interval were analyzed by the paired Student's t test. A p value < 0.05 was considered significant. Figure 1 shows one series of records that demonstrate changes in the configuration of last S1-and S2-TAPs. At any S1S1 intervals, S2-TAPD was shorter than S1-TAPD. S2-TAPD was monotonously shortened with a decrease in the S1S1 interval. The shortest S1S1 interval of 500 ms remarkably suppressed the plateau phase of S2-TAP, with a marked decrease in its duration (bottom of Figure 1A ). Figure 1B sum- marizes the relationship between S1S1 interval and S2-TAPD in 23 preparations tested. The decrease in S1S1 interval slightly but significantly reduced the amplitude of S2-TAP (Table) . The decrease in S1S1 interval did not significantly influence the resting membrane potential of S2-TAP (Table) . to an S1S1 interval of 500 ms was shorter than that in response to an S1S1 interval of 3000 ms (top of Figure 2A ). Increasing the [Ca 2+ ] o to 3.6 mM shortened S2-TAPD at both S1S1 intervals (middle of Figure 2A ). In contrast, perfusion with 0.9 mM [Ca 2+ ] o resulted in a prolongation of S2-TAPD at both S1S1 intervals. Thus, the S2-TAPD 30 in response to an S1S1 interval of 500 ms during 3.6 mM [Ca 2+ ] o perfusion was significantly shorter than that during 1.8 mM [Ca 2+ ] o perfusion (37 ± 3 vs 54 ± 4 ms, p < 0.01, n = 4, Figure 2B ), while that during 0.9 mM [Ca 2+ ] o perfusion was significantly longer than that during 1.8 mM [Ca 2+ ] o perfusion (84 ± 3 vs 54 ± 4 ms, p < 0.01, n = 4, Figure 2B ). Application of ouabain produced shortening of S2-TAPD in response to S1S1 intervals of both 3000 and 500 ms; the S2-TAPD 30 at the S1S1 interval of 500 ms after the application was significantly shortened (59 ± 3 vs 66 ± 3 ms, p < 0.05, n = 4). Application of verapamil at 5 µM slightly lengthened S2-TAPD 30 at all S1S1 intervals, but the lengthening effect was not significant at an S1S1 interval of 500 ms (52 ± 3 vs 48 ± 3 ms, p = ns, n = 4). Increasing the concentration of verapamil to 10 µM resulted in a significant prolongation of S2-TAPD 30 following an S1S1 interval of 500 ms (88 ± 4 vs 48 ± 3 ms, p < 0.01, n = 4). Figure 3A shows S2-TAPs obtained before and after the application of 2 µM ryanodine. Application of ryanodine abolished phase 1 of the action potential and increased the amplitude of its plateau level, which resulted in marked lengthening of S2-TAPD 30 at all S1S1 intervals tested. Thus, the S2-TAPD 30 in response to the S1S1 interval of 500 ms was significantly lengthened (138 ± 5 vs 55 ± 3 ms, p < 0.0001, n = 4, Figure 3B ). Figure 4A shows S2-TAPs obtained before and after the application of 1 and 10 mM 4-AP. Application of 1 mM 4-AP lengthened S2-TAPD following an S1S1 interval of 3000 ms, but the lengthening effect was inconspicuous in the S2-TAP following an S1S1 interval of 500 ms (middle of Figure 4A ). Increasing the concentration of 4-AP to 10 mM further lengthened S2-TAPD in response to an S1S1 interval of 3000 ms. However, the lengthening effect was not recognized in S2-TAP in response to the S1S1 interval of 500 ms (bottom of Figure 4A ). S2-TAPD 30 following the S1S1 interval of 500 ms, before and after the application of 1 and 10 mM 4-AP, was 62 ± 4, 63 ± 3 and 61 ± 5, respectively (p = ns for each, n = 4, Figure 4B ). Application of E-4031 caused marked prolongation of S2-TAPD recorded in response to an S1S1 interval of 3000 ms. However, at an S1S1 interval of 500 ms, the lengthening effect was inconspicuous at S2-TAPD 30 . Thus, S2-TAPD 30 in response to on S1S1 interval of 500 ms, before and after the application of 5 µM E-4031, was 56 ± 4 and 58 ± 4, respectively (p = ns, n = 4). Finally, we examined the effects of 3 µM glibenclamide in three preparations. Before and after the application, the configurations of S2-TAPs were almost identical, resulting in no significant difference in S2-TAPD 30 in response to an S1S1 interval of 500 ms (54 ± 3 vs 55 ± 4, p = ns, n = 3). In vivo experiments: Immediately before the pacing protocol, the intrinsic sinus cycle length, arterial systolic blood pressure, MAPD 30 and MAPD 90 of 5 rabbits tested were 253 ± 6 ms, 88 ± 3 mmHg, 101 ± 6 ms and 154 ± 8 ms, respectively. Figure 5A shows one series of records demonstrating changes in the configuration of S2-MAP in response to a progressive shortening in S1S1 intervals. In a manner similar to the results obtained in in vitro experiments, when the S1S1 interval was 700 ms, the S2-MAP showed a more prominent plateau level and a longer duration (top of Figure 5A) . However, when the S1S1 interval was decreased to 400 and 250 ms, S2-MAPs showed a decreased plateau phase along with a decrease in their duration (middle and bottom of Figure 5A ). Figure 5B shows the averaged S2-MAPD in 5 rabbits tested.
RESULTS
In vitro experiments:
Effects of potassium channel blockers:
DISCUSSION
Main finding: The main findings of the current study were: (1) increase in the stimulus frequency preceding the rest period potentiated the postrest shortening of the APD (frequency-dependent potentiation of the postrest shortening) in rabbit ventricle both in vitro and in vivo and (2) application of ryanodine is most effective in inhibiting the potentiation. Mechanisms: Since a long diastolic interval allows recovery from inactivation in the 4-AP sensitive Ito, the current has been attributed to the postrest shortening in the rabbit ventricular myocardium. [3] [4] [5] However, blockade of 4-AP sensitive Ito is not sufficient to completely abolish the postrest shortening.
3,4) Kukushkin, et al, reported that the substitution of strontium for Ca 2+ , in addition to 4-AP, was required to abolish postrest shortening. 4) We also reported that the postrest shortening was inhibited to a certain extent by the application of 4-AP at concentrations up to 10 mM. However, additional application of ryanodine was necessary to completely abolish the postrest shortening.
3) The long diastole increases utilization of activator Ca 2+ release from SR, resulting in a transient positive inotropy. [9] [10] [11] [12] This alteration of [Ca 2+ ] i transient may be involved in changes of action potential configuration after a rest period. In fact, Bers demonstrated that the APD of rabbit papillary muscle shortened after a rest period which was accompanied by a greater and faster developed tension. The author also showed that the shortened APD was almost reserved by the application of ryanodine or caffeine in association with the elimination of transient positive inotropy. 10) Although these observations strongly indicate an important role for SR in the regulation of APD after a long diastolic interval, the effects of preceding stimulus frequency on the postrest shortening have not been elucidated. To the best of our knowledge, only one study has described the experimental data from this point of view. Hilgemann used rabbit atrial myocardium to demonstrate that the action potential plateau was significantly suppressed after periods of quiescence with a marked positive inotropy and that the suppression of the plateau phase was potentiated by an increase in the preceding stimulus fre-quency.
12) The total APD after a rest period in response to the faster preceding stimuli, however, exhibited a prolongation because of the slow terminal repolarization. 12) In the present study using rabbit ventricular myocardium, since such a slow terminal repolarization was not observed, both the S2-TAPD 30 and S2-TAPD 90 after a rest period progressively shortened with an increase in preceding stimulus frequency. This discrepancy can be explained by distinct different distribution of ion channels between mammalian atria and ventricles. For instance, the ultrarapid delayed rectifier potassium current, which abbreviates APD, was reported to be abundant in atria and apparently absent in ventricles. 13, 14) In the present study, the most effective intervention to inhibit the potentiation of shortening was the application of ryanodine. The present study also demonstrated unique aspects of two potassium channel blockers, 4-AP and E-4031, on S2-TAPD in response to various S1S1 intervals. As described above, 4-AP blocks a component of Ito of which recovery from inactivation is slow. [3] [4] [5] On the other hand, E-4031 is a specific blocker of the rapid component of delayed rectifier potassium channel. 16) Both agents exhibited remarkable lengthening effects on S2-TAPD in response to long S1S1 interval. However, the lengthening effect was attenuated with shortening of the S1S1 interval and almost disappeared at the shortest S1S1 interval of 500 ms. Although the precise mechanisms were unclear, these observations may be explained by the mechanisms analogous to that of "reverse use-dependent" block of the potassium channel. 17) Many class III agents have been reported to prolong APD at low versus high frequency stimulation. Failure of lengthening APD after a rest period in response to the faster preceding stimuli by these two agents in the present study may be due to the unblocking of potassium channels during depolarization. However, because 4-AP and E-4031 block potassium currents in a "use-dependent" manner during diastole, only one long diastolic interval of 5000 ms following the high stimulus frequency may not be enough for the two agents to inhibit the potassium current. Finally, we tested the effects of an adenosine triphosphate (ATP)-sensitive potassium channel (K ATP channel) blocker, glibenclamide, on the frequency-dependent potentiation of the postrest shortening. Because the potentiation was not affected by application of glibenclamide, activation of K ATP channels due to intracellular ATP consumption by a high rate of stimulation is unlikely to be involved in the observations. Clinical implications: Our experimental situation appears to occur during the termination of supraventricular tachycardia or atrial fibrillation / flutter in patients with the bradycardia-tachycardia syndrome. These patients frequently exhibit a long pause upon the termination of tachycardia. When extrapolating our observations clinically, the repolarization after a pause may be facilitated. In fact, we recently reported two patients in whom a paradoxically shortened QT interval was observed after an abrupt prolonged pause. 18) One of the two patients indeed showed a marked shortening of QT interval following termination of supraventricular tachycardia. 18) Further studies are needed to estimate the relevance of frequency-dependent potentiation of the postrest shortening to ventricular arrhythmogenesis. Limitations: Several factors must be taken into account in interpreting our data. First, in in vitro experiments, the pacing protocol was performed using one set of regular stimuli for 60 s (S1). The duration of 60 s may not be long enough for the TAPD to reach a complete steady-state, especially when using long S1S1 intervals. Second, in in vivo experiments, we used electrical stimulation of the vagus nerve to slow sinus rhythm. In the intact heart, the autonomic nervous system preferentially controls cardiac electrophysiology. 19) Thus, the measurements of MAPD were only obtained under the limited condition in the present study.
